RHHBY

OTC Markets OTCQX

Roche Holding AG

Healthcare

Drug Manufacturers - General

Switzerland

54.77USD

+0.07 (+0.13%)

Market Cap: 352.77B USD

Revenue and Net Income

Values in CHF

No Annual revenue or net income data available.

Income Statement

Values in CHF

No income statement data available.

Key Statistics

Valuation

Market Cap (USD)352.77B

Market Cap (Local)352.77B

P/E (TTM)22.42

P/S (TTM)4.56

MC/EBITDA13.30

Volume & Shares

Last Volume3.16M

Avg Vol (10D)1.92M

Avg Vol (30D)1.88M

Avg Vol (90D)1.88M

Shares Outstanding6.44B

Growth Indicators

Revenue TTM/Ann1.00

Net Income TTM/Ann1.00

EBITDA TTM/Ann1.00

Gross Profit TTM/Ann1.00

Operating Inc TTM/Ann1.00

Currency & Exchange

Trading CurrencyUSD

Financial CurrencyCHF

Trading/USD Rate1.00

Financial/USD Rate1.22

ExchangeOTC Markets OTCQX

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others diagnostic instruments and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.